Raymond Hsu

🎓 Congratulations to our 2025 Nephrology Fellowship Graduates! 🩺

We are proud to send off this exceptional group of nephrologists who are ready to make an impact wherever they go. Here’s to the next chapter in your careers—your patients (and their kidneys) are in great hands.

Celebrating another successful year of our GN club with fellows and faculty @ucsfnephrology.bsky.social

#ASNCJASN welcomes original kidney health-focused artwork submissions for consideration on future covers. Creative, thought-provoking pieces are sought to reflect the impact of kidney health on individuals and communities. Submit your artwork today at www.editorialmanager....

Exploring the Optimal Blood Pressure Target in Advanced CKD Dr. Nozaina Mahmood is a Nephrology fellow at the University of Alabama at Birmingham with clinical and academic interests in chronic kidney disease, health disparities in nephrology, and evidence-…

Good write up of the @drraymondhsu.bsky.social et al BP trial in advanced CKD, on the @ajkd.bsky.social blog: ajkdblog.org/2025/05/28/e...

RCT here: www.ajkd.org/action/consu...

This #AAPIHeritageMonth, we’re raising awareness of how lupus impacts the AAPI community and why understanding health disparities is critical to creating change. Learn more: buff.ly/0I73RQ8

The Asian American and Pacific Islander (AAPI) community encompasses diverse cultures and languages. They face a disproportionate burden with #lupus. Lupus-related death rates among Hispanic and Asian women are 4–6 times higher than the general population.

Brown University Surgeon and Professor Are Deported to Lebanon Despite a Judge’s Order (Gift Article) Dr. Rasha Alawieh, a kidney transplant specialist and Brown University professor who had a valid visa, was expelled in apparent defiance of a court order.

The @nytimes.com with @danagoldstein.bsky.social cover the story of Dr Rasha Alawieh being deported despite the Judge’s order (gift link)

(She’s a nephrologist, not a surgeon, but that doesn’t matter here)

www.nytimes.com/2025/03/16/u...

Welcome to #NephMadness 2025 Here it is, the 13th edition of NephMadness!  Whether you’re new to the competition or just want to relive past glories, we have all the info you need for NephMadness 2025: What is NephMadnes…

#NephMadness 2025 is live on the #AJKDBlog: bit.ly/WelcomeNM25

Topics include:
- Resistant Hypertension
- Obesity
- Green House
- Minimal Change Disease
- Disaster Nephrology
- Genetics
- Hemodialysis
- CAR-T for Kidney Disease

Looking forward to the fun and learning with all of you!

It is a full fledge assault on medical research. Turning off funding, canceling grants, and disabling the tools we use. It is a complete dismantling of the infrastructure.

NKF Statement on Mass Staff Terminations at HHS

We urge the Administration and Congress to reconsider and roll back these actions immediately so potential cuts can be made in a thoughtful and safer manner. To do otherwise may result in absolute tragedy for the American people.

Love this panel. Let the #blueribbonfail roasting begin!

Atrasentan for IgA Nephropathy A Research Summary based on Heerspink HJL et al. | 10.1056/NEJMoa2409415 | Published on October 25, 2024

In a prespecified interim analysis of a phase 3, randomized, controlled trial, the selective endothelin type A receptor antagonist atrasentan reduced proteinuria in patients with IgA nephropathy, without apparent safety issues. Full ALIGN trial results: nej.md/3NzvISW

#MedSky #Nephrology

Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis | NEJM Obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, provided significantly better renal responses than placebo in a phase 2 trial involving patients with lupus nephritis receiving stan...

In the REGENCY trial, obinutuzumab, a humanized type II anti-CD20 monoclonal antibody, plus standard therapy provided significantly better renal responses than standard therapy alone in patients with lupus nephritis. Full trial results: nej.md/3Eq6gxV

#ISNWCN | @theisn.org

This is the front page of a fraudulent research article that purported to show a link between vaccines and autism. The word "RETRACTED" is written across it in large red letters. Wikipedia: On 28th February 1998, a fraudulent research paper by physician Andrew Wakefield and twelve coauthors, titled "Ileal-Lymphoid-Nodular Hyperplasia, Non-Specific Colitis, and Pervasive Developmental Disorder in Children", was published in the British medical journal The Lancet.[1] The paper falsely claimed causative links between the measles, mumps, and rubella (MMR) vaccine and colitis and between colitis and autism. The fraud involved data selection, data manipulation, and two undisclosed conflicts of interest.

Today is Retraction Day, when we observe the anniversary of the retraction (Feb. 2, 2010) of the fraudulent paper that purported to show a link between vaccines and autism. 🧪#medsky

FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

BREAKING NEWS: The FDA has approved Ozempic for patients with chronic kidney disease. This means the popular injection can be used to reduce the risk of kidney disease worsening, kidney failure and death from cardiovascular disease in patients with chronic kidney disease and diabetes.

Nor am I!

Thx for clarifying. I guess I got overzealous in defending whichever of my colleagues (esp if fellow) you were debating with! 😭😛

Now, the contemporary true incidence of contrast AKI is likely very low owing to less nephrotoxic contrast(lower osmolality), lower volumes used, attention to care on whom to avoid if not necessary, more pervasive preventive protocols (IVF), etc etc.

Contrast-induced or associated AKI is absolutely real. Saying that it doesn’t exist means ur insulting generations of colleagues who came b4 us who observed/studied this phenomenon b4 our time and saying that it’s always been a fictitious entity in their minds.

a man in a black shirt says " don 't do this " in white letters ALT: a man in a black shirt says " don 't do this " in white letters

Infamous Phantom Nephro Recs:
1. Avoid nephrotoxins (pt needs atbxs + CTA)
2. Keep MAP >65 (on the floor, not on pressors)
3. Trend Cr daily (already ✔️BMPs q 8h happening)
4. Strict I/Os (on diapers, refuses Foley/PureWick)
5. Renally dose all meds (pt not on any renally cleared med)

An opposing view would be to throw caution to the wind and implement GDMT at a more accelerated rate similar to CHF

journals.lww.com/cjasn/fullte...

@asnkidney.bsky.social #CJASN
@brendonneuen.bsky.social

#NephJC

It has taken more than 4 years but the methodologically poor (doi.org/10.1016/j.th...) and questionable paper (1-day peer review bmcmedresmethodol.bi...) that promoted HCQ for COVID-19 is finally retracted. We've been saying for years it had to be (doi.org/10.1016/j.th...).

Furthermore corticosteroids increase cystatin C as well

Immunofluorescence Use and Techniques in Glomerular Diseases: A Review Abstract. Background: Immunofluorescence (IF) studies play an essential role in the evaluation of medical renal biopsies. Particularly, in the study of renal glomerular diseases, where it provides fun...

So very happy with this publication! I hope it will assist trainees in #nephrology and #renalpath in the uses of IF.

karger.com/gdz/article/...

Thank you @saynanorouzi.bsky.social for the invite and congrats on a phenomenal conference! #bluezone

Celebrating the holidays with @ucsfnephrology.bsky.social GN Club including several alumni of our fellowship GN track

Women as leaders bring many benefits!!

Our own @drraymondhsu.bsky.social speaking on IgA nephropathy and lupus nephritis

We are excited to welcome our incoming class of Nephrology fellows, and we look forward to the innovative contributions, passion, and dedication they will bring to our program and the field of nephrology.

Welcome to the UCSF Nephrology family! 😊

A Stanford Professor’s Wife Recruited People For His Coronavirus Study By Claiming It Would Reveal If They Could “Return To Work Without Fear” An email sent to a Silicon Valley middle school’s private listserv tried to recruit families for the antibody study, promising “peace of mind” about their immunity to the coronavirus.

The research misconduct here is also disturbing

www.buzzfeednews.com/article/step...